Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study.
Arthritis Rheum. 2013 Jan;65(1):28-38. doi: 10.1002/art.37711.
Arthritis Rheum. 2013.
PMID: 23169319
Free PMC article.
Clinical Trial.